
Resultados de la búsqueda
Results found for "silence therapeutics"
- Webinar: Silence Therapeutics and Their Work with MPNs
The Global MPN Scientific Foundation is pleased to host a special webinar introducing Silence Therapeutics Date: May 20th, 2025 Time: 6:00 PM – 7:00 PM (CEST) About Silence Therapeutics Silence Therapeutics Silence Therapeutics collaborates globally to drive forward science that can make a real impact on I have been in the pharmaceutical industry for 25 years helping mostly small companies like Silence Therapeutics The webinar will cover: An overview of Silence Therapeutics’ scientific approach and platform Their current
- Video | A New Possible Treatment for PV with Silence Therapeutics
On May 20th, 2025, the Global MPN Scientific Foundation hosted a webinar featuring Silence Therapeutics
- Videos | Webinar: New Treatment for PV with Prof. Susanne Isfort and Silence Therapeutics
Therapeutics , a biotech company developing precision RNA-based therapies for rare diseases such as Alberto Martinez , Senior Director of Clinical Science at Silence Therapeutics. Content guide Part 1: Silence Therapeutics and a Promising New Treatment for PV Watch More on MPN World Part 1: Silence Therapeutics and a Promising New Treatment for PV In the first part, Alberto Martinez Therapeutics is advancing innovative approaches that could help reduce phlebotomies and improve quality
- Webinar: Clinical Trials, PV and the Future. A Live Conversation with Dr. Susanne Isfort and Silence Therapeutics
Following the success of our first webinar with Silence Therapeutics , we are excited to announce the This time, we continue on Silence Therapeutics and their investigational therapy for Polycythemia Vera About Silence Therapeutics Webinar Details Register now What to Expect? Alberto Martinez ( Senior Director of Clinical Science at Silence Therapeutics )He will continue explaining About Silence Therapeutics Silence Therapeutics is a UK-based biotech company developing precision RNA-based
- Season’s Greetings from the Global MPN Family
We also hosted and supported webinars on ongoing clinical trials , including sessions with: Silence Therapeutics
- Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset
Takeda and Protagonist Therapeutics, Inc. , today announced the signing of a worldwide license and collaboration Patel, Ph.D., President and CEO of Protagonist Therapeutics .
- One MPN Family: YouTube Videos, Summary & Highlights from the 5th MPN Spring Symposium
The first presentation was given by Alberto Martínez , Senior Director of Clinical Science at Silence Therapeutics , who shared insights on RNA based approaches in MPNs and how patient-reported outcomes
- Are you feeling fatigued?
But you don't have to suffer in silence. But you don't have to suffer in silence.
- Videos from the Webinar with Dr. Serge Verstovsek on the Future of MPN Treatment
Verstovsek, world-leading MPN researcher The Global MPN Scientific Foundation, in collaboration with Kartos Therapeutics Content Guide PART 1 – A New Era: Navtemadlin and the Therapeutic Approach Want to watch Parts 2 and Why this matters PART 1 – A New Era: Navtemadlin and the Therapeutic Approach Dr.
- Recognizing Excellence: Highlights from the 3rd MPN Spring Symposium Awards Ceremony
Hugh Rienhoff MPN Voice UK Protagonist Therapeutics Let's honor and learn from the awardees: Prof. Summary Transcription Protagonist Therapeutics The award ceremony recognizes Protagonist Therapeutic for its innovative work in developing a new therapeutic product.
- Virtual Meeting: Regain your strength - 30th January
this session, we will focus on the first stage post-diagnosis and engage in automatic writing as a therapeutic Register now and don’t miss out on this unique opportunity to explore the therapeutic benefits of writing
- Webinar | Introduction to Geron
caregivers , and healthcare professionals to gain insight into the latest research and innovative therapeutic












